Pulmonary Disorders and COVID-19: Difference between revisions

Jump to navigation Jump to search
Tag: New redirect
 
(33 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[COVID-19 Pulmonary Complications]]
To go to the COVID-19 project topics list, click '''[[COVID-19 Project Topics|here]]'''.
 
{{CMG}} {{AE}} {{S.M.}}
==Overview==
 
==Complications==
 
===Acute respiratory distress syndrome===
*
 
===Pneumonia===
 
===Pulmonary embolism===
 
===Hypoxemia===
 
===Superinfection===
 
===Respiratory failure===
 
===Increased mortality in COPD patients===
*According to a study conducted in China, having an underlying comorbidity such as chronic obstructive pulmonary disease (COPD) conferred a mortality hazard ratio of 2.681, even after adjusting for smoking status.<ref name="pmid32217650">{{cite journal| author=Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM | display-authors=etal| title=Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. | journal=Eur Respir J | year= 2020 | volume= 55 | issue= 5 | pages=  | pmid=32217650 | doi=10.1183/13993003.00547-2020 | pmc=7098485 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32217650  }} </ref><ref>https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2763184</ref><ref>https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2763184</ref><ref name="pmid32145829">{{cite journal| author=Ñamendys-Silva SA| title=Respiratory support for patients with COVID-19 infection. | journal=Lancet Respir Med | year= 2020 | volume= 8 | issue= 4 | pages= e18 | pmid=32145829 | doi=10.1016/S2213-2600(20)30110-7 | pmc=7129706 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32145829  }} </ref>
 
==References==

Latest revision as of 01:29, 24 June 2020